中文产业新闻评分57Chinese source
礼来在2026 EASD公布eloralintide与替尔泊肽联合治疗EloraTZP 2b期48周减重结果
2026EASD | 礼来公布胰淀素受体激动剂eloralintide与替尔泊肽联合治疗研究结果
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
2026EASD | 礼来公布胰淀素受体激动剂eloralintide与替尔泊肽联合治疗研究结果
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.